Cargando…
Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation
BACKGROUND: Diabetes mellitus (DM) is a common and increasingly prevalent condition in patients with atrial fibrillation (AFib). The left atrium appendage (LAA), a small outpouch from the LA, is the most common location for thrombus formation in patients with AFib. HYPOTHESIS: In this study, we exam...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954381/ https://www.ncbi.nlm.nih.gov/pubmed/31755572 http://dx.doi.org/10.1002/clc.23292 |
_version_ | 1783486786722332672 |
---|---|
author | Yosefy, Chaim Pery, Marina Nevzorov, Roman Piltz, Xavier Osherov, Azriel Jafari, Jamal Beeri, Ronen Gallego‐Colon, Enrique Daum, Aner Khalameizer, Vladimir |
author_facet | Yosefy, Chaim Pery, Marina Nevzorov, Roman Piltz, Xavier Osherov, Azriel Jafari, Jamal Beeri, Ronen Gallego‐Colon, Enrique Daum, Aner Khalameizer, Vladimir |
author_sort | Yosefy, Chaim |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM) is a common and increasingly prevalent condition in patients with atrial fibrillation (AFib). The left atrium appendage (LAA), a small outpouch from the LA, is the most common location for thrombus formation in patients with AFib. HYPOTHESIS: In this study, we examined LAA remodeling differences between diabetic and nondiabetic patients with AFib. METHODS: This retrospective study analyzed data from 242 subjects subdivided into two subgroups of 122 with DM (diabetic group) and 120 without DM (nondiabetic group). The study group underwent real‐time 3‐dimensional transesophageal echocardiography (RT3DTEE) for AFib ablation, cardioversion, or LAA device closure. The LAA dimensions were measured using the “Yosefy rotational 3DTEE method.” RESULTS: The RT3DTEE analysis revealed that diabetic patients display larger LAA diameters, D1‐lengh (2.09 ± 0.50 vs 1.88 ± 0.54 cm, P = .003), D2‐width (1.70 ± 0.48 vs 1.55 ± 0.55 cm, P = .024), D3‐depth (2.21 ± 0.75 vs 1.99 ± 0.65 cm, P = .017), larger orifice areas (2.8 ± 1.35 and 2.3 ± 1.49 cm(2), P = .004), and diminished orifice flow velocity (37.3 ± 17.6 and 43.7 ± 19.5 cm/sec, P = .008). CONCLUSIONS: Adverse LAA remodeling in DM patients with AFib is characterized by significantly LAA orifice enlargement and reduced orifice flow velocity. Analysis of LAA geometry and hemodynamics may have clinical implications in thrombotic risk assessment and treatment of DM patients with AFib. |
format | Online Article Text |
id | pubmed-6954381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69543812020-01-14 Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation Yosefy, Chaim Pery, Marina Nevzorov, Roman Piltz, Xavier Osherov, Azriel Jafari, Jamal Beeri, Ronen Gallego‐Colon, Enrique Daum, Aner Khalameizer, Vladimir Clin Cardiol Clinical Investigations BACKGROUND: Diabetes mellitus (DM) is a common and increasingly prevalent condition in patients with atrial fibrillation (AFib). The left atrium appendage (LAA), a small outpouch from the LA, is the most common location for thrombus formation in patients with AFib. HYPOTHESIS: In this study, we examined LAA remodeling differences between diabetic and nondiabetic patients with AFib. METHODS: This retrospective study analyzed data from 242 subjects subdivided into two subgroups of 122 with DM (diabetic group) and 120 without DM (nondiabetic group). The study group underwent real‐time 3‐dimensional transesophageal echocardiography (RT3DTEE) for AFib ablation, cardioversion, or LAA device closure. The LAA dimensions were measured using the “Yosefy rotational 3DTEE method.” RESULTS: The RT3DTEE analysis revealed that diabetic patients display larger LAA diameters, D1‐lengh (2.09 ± 0.50 vs 1.88 ± 0.54 cm, P = .003), D2‐width (1.70 ± 0.48 vs 1.55 ± 0.55 cm, P = .024), D3‐depth (2.21 ± 0.75 vs 1.99 ± 0.65 cm, P = .017), larger orifice areas (2.8 ± 1.35 and 2.3 ± 1.49 cm(2), P = .004), and diminished orifice flow velocity (37.3 ± 17.6 and 43.7 ± 19.5 cm/sec, P = .008). CONCLUSIONS: Adverse LAA remodeling in DM patients with AFib is characterized by significantly LAA orifice enlargement and reduced orifice flow velocity. Analysis of LAA geometry and hemodynamics may have clinical implications in thrombotic risk assessment and treatment of DM patients with AFib. Wiley Periodicals, Inc. 2019-11-22 /pmc/articles/PMC6954381/ /pubmed/31755572 http://dx.doi.org/10.1002/clc.23292 Text en © 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Yosefy, Chaim Pery, Marina Nevzorov, Roman Piltz, Xavier Osherov, Azriel Jafari, Jamal Beeri, Ronen Gallego‐Colon, Enrique Daum, Aner Khalameizer, Vladimir Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title | Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title_full | Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title_fullStr | Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title_full_unstemmed | Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title_short | Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
title_sort | difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954381/ https://www.ncbi.nlm.nih.gov/pubmed/31755572 http://dx.doi.org/10.1002/clc.23292 |
work_keys_str_mv | AT yosefychaim differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT perymarina differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT nevzorovroman differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT piltzxavier differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT osherovazriel differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT jafarijamal differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT beerironen differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT gallegocolonenrique differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT daumaner differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation AT khalameizervladimir differenceinleftatrialappendageremodelingbetweendiabeticandnondiabeticpatientswithatrialfibrillation |